Remimazolam Tosilate Sedation and Midazolam Sedation in Dental Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

December 31, 2021

Conditions

Sedation ComplicationMidazolamRemimazolam

Interventions

DRUG

Fentanyl

50ug Fentanyl intravenously

DRUG

Flurbiprofen

50mg Fentanyl intravenously

DRUG

Midazolam

2.5mg midazolam in 2ml normal saline intravenously

DRUG

Remimazolam

3mg Remimazolam in 2ml normal saline intravenously

Trial Locations (2)

Peking University Hospital of Stomatology, Beijing

Zijian Guo, Haidian

All Listed Sponsors

lead

Peking University

OTHER

NCT04602845 - Remimazolam Tosilate Sedation and Midazolam Sedation in Dental Patients | Biotech Hunter | Biotech Hunter